“…The use of EUS in the work-up of children with pancreatobiliary pathology may limit exposure to risk of adverse events from ERCP [152]. MRCP and ERCP may be used—the first to document the communication of the cyst with the main pancreatic duct [40, 41, 45, 49, 68, 71, 97, 128, 138, 145, 154, 156, 247, 253, 259, 261] and, the latter, for treating the disease.…”